D. Elkins

Role of HPC 2 / ELAC 2 in Hereditary Prostate Cancer 1

J. Cerhan, D. Schaid, S. Thibodeau, 2001 .

Luteinizing hormone β polymorphism and risk of familial and sporadic prostate cancer

S. Thibodeau, S. McDonnell, J. Cunningham, 2003 .

Status of Ribozyme and Antisense‐Based Developmental Approaches for Anti‐HIV‐1 Therapy a

J. Rossi, J. Zaia, N. Taylor, 1992, Annals of the New York Academy of Sciences.

Ribozymes as anti-HIV-1 therapeutic agents: principles, applications, and problems.

J. Rossi, S. Sullivan, J. Zaia, 1992, AIDS research and human retroviruses.

Analysis of the RNASEL gene in familial and sporadic prostate cancer.

J. Cerhan, D. Schaid, S. Thibodeau, 2002, American journal of human genetics.

Role of HPC2/ELAC2 in hereditary prostate cancer.

J. Cerhan, D. Schaid, S. Thibodeau, 2001, Cancer research.

Polymerase chain reaction detection of human immunodeficiency virus DNA in human periradicular lesions.

M. Torabinejad, J. Kettering, J. Rossi, 1994, Journal of endodontics.

Exploring the use of antisense, enzymatic RNA molecules (ribozymes) as therapeutic agents.

J. Rossi, S. Sullivan, J. Zaia, 1991, Antisense research and development.